SECURITIES AND EXCHANGE COMMISSION
                   WASHINGTON, D.C.  20549

                        ----------------

                            FORM 10-Q

    [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
     THE SECURITIES EXCHANGE ACT OF 1934 FOR THE PERIOD ENDED   
                        SEPTEMBER 30, 1997
                              OR
    [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
              OF THE SECURITIES EXCHANGE ACT OF 1934
               FOR THE TRANSITION PERIOD FROM     TO 

                        ----------------

                Commission file number 0-18160

                         4HEALTH, INC.
       (Exact name of registrant as specified in its charter)

                        ----------------

            Utah                         87-0468225
   (State of incorporation) (I.R.S. Employer Identification No.)

                      5485 Conestoga Court
                    Boulder, Colorado  80301
              (Address of principal executive offices)
          Registrant's telephone number:  (303) 546-6306

                        ----------------

The following items were subject to a Form 12b-25 and are
omitted from this report: Part I, Item 1 and Part I, Item 2.

Indicate by check mark whether the registrant (1) has filed all 
reports required to be filed by Section 13 or 15(d) of the 
Securities Exchange Act of 1934 during the preceding 12 months 
(or for such shorter period that the registrant was required to 
file such reports), and (2) has been subject to such filing 
requirements for the past 90 days.  Yes:     X        No:        

The number of shares of the registrant's Common Stock, par value 
$.01 per share, outstanding as of September 30, 1997 was 
11,905,920.



4Health, Inc.
Index  to Form 10-Q
<TABLE>
<CAPTION>
<S>                                                      <C>
PART I.  FINANCIAL INFORMATION                           Page
              
Item 1.  Financial Statements ...........................  3
              
Item 2.  Management's Discussion and Analysis of Financial
    Condition and Results of Operations .................  3
              
PART II. OTHER INFORMATION        
              
Item 1.  Legal Proceedings ..............................  3
              
Item 5.  Other Information ..............................  3
              
Item 6.  Exhibits and Reports on Form 8-K ...............  4
              
    SIGNATURES ..........................................  8
</TABLE>
    This Quarterly Report on Form 10-Q includes "forward-looking 
statements" within the meaning of Section 27A of the Securities
Act of 1933, as amended (the "Securities Act") and Section 21E of
the Securities Exchange Act of 1934, as amended (the "Exchange
Act").  All statements other than statements of historical facts
included in this Quarterly Report, including, without limitation,
those regarding the Company's financial position, business,
marketing and product introduction and development plans and 
objectives of management for future operations, are forward-
looking statements.  Although the Company believes that the
expectations reflected in such forward-looking statements are
reasonable, it can give no assurance that such expectations will
prove to have been correct.  Important factors that could cause
actual results to differ materially from the Company's
expectations ("Cautionary Statements") are disclosed under "Risks
Related to the Business of 4Health" and elsewhere in the
Company's Annual Report on Form 10-K dated March 27, 1997 and in
"Management's Discussion and Analysis of Financial Condition and
Results of Operations" and elsewhere in the Annual Report.  All
subsequent written and oral forward-looking statements
attributable to the Company or persons acting on behalf of the
Company, are expressly qualified in their entirety by the
Cautionary Statements. 





PART I.  FINANCIAL INFORMATION
Item 1.       Financial Statements

    The information required to be furnished in this is the 
subject of a Form 12b-25 and has therefore been omitted from this 
report.

Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations

    The information required to be furnished in this is the 
subject of a Form 12b-25 and has therefore been omitted from this 
report.

PART II. OTHER INFORMATION

Item 1.  Legal Proceedings

    On July 10, 1997, 4Health, Inc. was served notice of a law 
suit filed against the company by the Richard's Group, Inc.  The 
action, Richard's Group, Inc. vs. 4Health, Inc. (97-05669-L), was 
filed in the District Courts of Dallas County, Texas on June 20, 
1997.  The action requested judgment be made by the Court against 
4Health, Inc. regarding outstanding fees in the amount of 
$61,839.92, interest, and legal expenses incurred by the 
plaintiff in this matter.  The action alleged that these fees 
were incurred by the Company for advertising services provided by 
the plaintiff.  On October 30, 1997, the Company executed a 
settlement agreement with the Richard's Group which included a 
payment of $54,000 and a dropping of all claims.

Item 5.  Other Information

    During the third quarter of 1997, the Company signed an 
agreement with Norwest Business Credit, Inc. to provide a 
revolving line of credit of up to $1.5 million.  A summary of the 
terms of the revolving line of credit is filed as Exhibit 5.01 to 
this Form 10-Q according to Rule SK 601.

    On September 26, 1997 the Company issued 500,000 registered 
shares of common stock in accordance with Agreement and Plan of 
Merger dated April 10, 1996, by and between 4health, Inc., and 
Surgical Technologies, Inc. as amended June 4, 1996.  (A copy of 
this agreement is filed as Exhibit 2.01 and incorporated by 
reference from Surgical Technologies, Inc.'s registration 
statement on Form S-4 filed with the Commission, SEC file number 
33-03243.)  The agreement specified that additional shares were 
to be issued to original 4health, Inc. shareholders if a certain 
operating unit of Surgical Technologies, Inc. did not generate a 
certain level of income.
Item 6.       Exhibits and Reports on Form 8-K

Exhibit Index

Item 2.  Plan of Acquisition, Reorganization, Liquidation, or 
Succession

2.01          Agreement and Plan of Merger dated April 10, 1996, by 
and between 4health, Inc., and Surgical Technologies, Inc. as 
amended June 4, 1996. Incorporated by Reference (4).

2.02          Asset Purchase Agreement dated November 30, 1995, by 
and between Microtek Medical, Inc., and Surgical Technologies, 
Inc. Incorporated by Reference (3).

2.03     2    Acquisition Agreement dated effective January 1, 1996, 
by and between Rex Industries Acquisition Corporation and Rex 
Industries, Inc.  Incorporated by Reference (3).

Item 3.  Articles of Incorporation and Bylaws    

3.01          Articles of Incorporation of Surgical Subsidiary, Inc., 
a Utah Corporation now known as Surgical Technologies, Inc. 
Incorporated by Reference (6).

3.02          Articles of Merger and related Plan of Merger. 
Incorporated by Reference (6).

3.03          Bylaws. Incorporated by Reference (6).

3.04          Articles of Merger and related Plan of Merger. 
Incorporated by Reference (4).

Item 4.  Instruments Defining the Rights of Security Holders

4.01          Form of Warrant Agreement between 4Health, Inc. and 
Zions First National Bank with related form of Warrant. 
Incorporated by Reference (4).

4.02          Form of Sale Restriction Agreement respecting 
shareholders of both Surgical Technologies, Inc., and 4Health, 
Inc.     Incorporated by Reference (4).

4.03          Form of Consent, Approval, and Irrevocable Proxy 
respecting certain Surgical stockholders with related schedule. 
Incorporated by Reference (4).

4.04          Form of Consent, Approval, and Irrevocable Proxy 
respecting certain 4Health stockholders with related schedule. 
Incorporated by Reference (4).

4.05          Specimen Common Stock Certificate. Incorporated by
Reference (4).

4.06          Specimen Warrant Certificate. Incorporated by
Reference (4).

4.07          Warrant certificates between 4Health and Allen & 
Company Incorporated dated April 15, 1997. Incorporated by
Reference (8).
              
Item 5.  Other Items

5.01          Summary of Revolving Line of Credit Agreement between 
4Health and Norwest Business Credit, Inc. This Filing.
              
Item 10. Material Contracts

10.01    Form of Directors' Options. Incorporated by
Reference (3)*.

10.02    Stock Option and Stock Award Plan. Incorporated by
Reference (3)*.

10.03    1991 Directors' Stock Option Plan. Incorporated by
Reference (3)*.

10.04    Directors' Stock Option Plan. Incorporated by
Reference (5)*.

10.05    Technology Purchase Agreement between Ellis E. 
Williams, Professional Medical, Inc., and Surgical Technologies, 
Inc., dated February 4, 1993. Incorporated by Reference (6).

10.06    Patent Cross-License Agreement between Utah Medical 
Products, Inc., and Professional Medical, Inc., dated February 9, 
1993. Incorporated by Reference (7).
              
10.07    Form of Promissory Note in the amount of $1,000,000 
payable to First Interstate Bank, dated August 16, 1994. 
Incorporated by Reference (7).
              
10.08    Deed of Trust Note and related Deed of Trust, 
Assignment of Rents, Security Agreement, and Fixture Filing, 
dated April 8, 1994, in the principal amount of $1,000,000 due 
Standard Insurance Company. Incorporated by Reference (6).

10.09    Stock Purchase Agreement dated May 6, 1994, between 
Surgical Technologies, Inc., and Benitex, A.G. Incorporated by 
Reference (6).

10.10    Real Estate Contract dated February 2, 1994, between 
Surgical Technologies, Inc. and Rex Crosland related to the 
facilities at 2801 South Decker Lake Lane, Salt Lake City, Utah. 
Incorporated by Reference (6).

10.11    Asset Purchase Agreement between Milwaukee Acquisition 
Company, Insulation Distributors, Inc., and Surgical 
Technologies, Inc., effective September 30, 1993. Incorporated by 
Reference (6).

10.12    All-Inclusive Promissory Note and related All-Inclusive 
Trust Deed, relating to sale of building and property, dated 
March 31, 1995, in the principal amount of $981,375.32. 
Incorporated by Reference (7).

10.13    1996 Long-Term Stock Incentive Plan. Incorporated by 
Reference (4).

10.14    Form of $2.00 option granted to Surgical directors, 
officers, and employees with related schedule. Incorporated by
Reference (4)*.

10.15    Form of Option granted to Todd B. Crosland. 
Incorporated by Reference (4)*.
              
10.16    Form of Option granted to Rockwell D. Schutjer. 
Incorporated by Reference (4)*.
              
10.17    Form of Proprietary Information, Inventions, and Non-
Competition Agreement between 4Health and R. Lindsey Duncan. 
Incorporated by Reference (4).

10.18    Form of Employment Agreement between the Surviving 
Corporation and Rockwell D. Schutjer. Incorporated by
Reference (4)*.

10.19    Deed of Trust Note and related Deed of Trust, 
Assignment of Rents, Security Agreement, and Fixture Filing, 
dated February 20, 1997, in the principal amount of $1,350,000 
due Standard Insurance Company. Incorporated by Reference (2).

Item 20. Other Documents or Statements to Security Holders

20.01    Notice of change of transfer and warrant agent. 
Incorporated by Reference (1).
              



Item 27. Financial Data Schedule

27.01    Financial Data Schedule. Subject to a Form 12b-25 and 
therefore omitted from this filing.
              
(1)      Incorporated by reference from 4Health's report on Form
10-Q for the quarter ended March 31, 1997.
(2)      Incorporated by reference from 4Health's report on Form
10-K for the year ended December 31, 1996.
(3)      Incorporated by reference from Surgical's registration
statement on Form S-1 filed with the Commission, SEC file number
33-31863.
(4)      Incorporate by reference from Surgical's registration
statement on Form S-4 filed with the Commission, SEC file number
33-03243.
(5)      Incorporated by reference from Surgical's report on
Form 10-K for the year ended March 31, 1992.
(6)      Incorporated by reference from Surgical's report on
Form 10-K for the year ended March 31, 1994.
(7)      Incorporated by reference from Surgical's report on
Form 10-Q for the quarter ended December 31, 1995.
(8)      Incorporated by reference from Schedule 13D filed with
the Commission by Allen & Company Incorporated on April 18, 1997.
*        Represents a management contract, compensatory plan, or
arrangement required to be filed as an exhibit.

























                        Signatures 

    Pursuant to the requirements of the Securities Exchange Act 
of 1934, the registrant has duly caused this report to be signed 
on its behalf by the undersigned thereunto duly authorized.


4Health, Inc.

Dated: October 13, 1997
By:/s/ R. LINDSEY DUNCAN
R. Lindsey Duncan
President and Chief 
Executive Officer

Dated: October 13, 1997
By:/s/ SCOTT W. LUSK
Scott W. Lusk
Controller (Principal Accounting Officer)